more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

Bottom 42% (145 out of 250)

Industry: Medical Services

View All Zacks #1 Ranked Stocks

Zacks News

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research Published on January 30,2019

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HQYPositive Net Change

Will HealthEquity, Inc. (HQY) Continue to Surge Higher?

by Zacks Equity Research Published on January 28,2019

As of late, it has definitely been a great time to be an investor in HealthEquity, Inc.

HQYPositive Net Change

medical

Is HealthEquity (HQY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research Published on January 25,2019

Is (HQY) Outperforming Other Medical Stocks This Year?

HQYPositive Net Change

Teladoc Expands Services with Virtual Back Pain Treatment

by Zacks Equity Research Published on January 21,2019

Teladoc's (TDOC) new addition of virtual back pain treatment will broaden its suite of products and services.

medical

Here is Why Growth Investors Should Buy HealthEquity (HQY) Now

by Zacks Equity Research Published on January 18,2019

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

HQYPositive Net Change

3 Medical Services Stocks to Buy in 2019: HQY, AMEH & OPGN

by Sreyoshi Mukherjee Published on January 11,2019

Here we discuss three profitable Medical Services stocks as the industry booms.

medical

Why Is HealthEquity (HQY) Down 29.3% Since Last Earnings Report?

by Zacks Equity Research Published on January 03,2019

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HQYPositive Net Change

Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research Published on January 01,2019

Is (HQY) Outperforming Other Medical Stocks This Year?

HQYPositive Net Change

MEDP or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on December 27,2018

MEDP vs. HQY: Which Stock Is the Better Value Option?

Here's Why You Should Hold HealthEquity (HQY) Stock for Now

by Zacks Equity Research Published on December 19,2018

HealthEquity's (HQY) fiscal third-quarter results hold promise while competition is stiff.

medical

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research Published on December 13,2018

Is (HQY) Outperforming Other Medical Stocks This Year?

HQYPositive Net Change

Why HealthEquity (HQY) Isn't Done Growing Earnings Yet

by Zacks Equity Research Published on December 10,2018

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

HQYPositive Net Change

medical

ESRX vs. HQY: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on December 06,2018

ESRX vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q3

by Zacks Equity Research Published on December 05,2018

HealthEquity's (HQY) impressive results in Q3 can be attributed to solid growth in HSA Members. Its bullish guidance for fiscal 2019 further raises investors' optimism on the stock.

HealthEquity (HQY) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on December 04,2018

HealthEquity (HQY) delivered earnings and revenue surprises of 12.00% and 1.06%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?

HQYPositive Net Change

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research Published on November 27,2018

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HQYPositive Net Change

Will HSA Member Growth Aid HealthEquity's (HQY) Q3 Earnings?

by Zacks Equity Research Published on November 27,2018

HealthEquity's (HQY) top line is likely to be driven by solid Health Savings Accounts (HSA) member growth in the fiscal third quarter. However, cutthroat competition in the niche space is concerning.